According to Mainz Biomed's latest financial reports the company has $7.07 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $17.14 M | 96.41% |
2021-12-31 | $8.72 M | 7020.57% |
2020-12-31 | $0.12 M | -39.8% |
2019-12-31 | $0.2 M |